| Literature DB >> 23118551 |
Jane S Saczynski1, Ezra Gabbay, David D McManus, Richard McManus, Joel M Gore, Jerry H Gurwitz, Darleen Lessard, Robert J Goldberg.
Abstract
BACKGROUND ANDEntities:
Keywords: cardiology; end of life; epidemiology; longitudinal; myocardial infarction; survival
Year: 2012 PMID: 23118551 PMCID: PMC3484503 DOI: 10.2147/CLEP.S32034
Source DB: PubMed Journal: Clin Epidemiol ISSN: 1179-1349 Impact factor: 4.790
Changing trends in the use of do-not-resuscitate orders in patients hospitalized with acute myocardial infarction (AMI) (Worcester Heart Attack Study)10
| Study years | Model 1 | Model 2 |
|---|---|---|
|
|
| |
| Odds ratio (95% CI) | Odds ratio (95% CI) | |
| 2001 | 1.0 | 1.0 |
| 2003 | 1.00 (0.80, 1.25) | 1.10 (0.87, 1.39) |
| 2005 | 1.05 (0.83, 1.32) | 1.17 (0.92, 1.50) |
| 2007 | 0.99 (0.77, 1.28) | 1.17 (0.89, 1.54) |
Notes:
Referent year;
adjusted for age, sex, comorbid conditions (history of angina, diabetes, hypertension, heart failure), and AMI-associated characteristics (AMI order, location, and type);
additional adjustments for development of hospital complications (atrial fibrillation, heart failure, cardiogenic shock, stroke), and in-hospital medications (angiotensin-converting-enzyme inhibitors, anticoagulants, aspirin, beta-blockers, calcium antagonists, thrombolytic therapy).
Abbreviation: CI, confidence interval.
Figure 1Trends in the use and timing of do-not-resuscitate (DNR) orders in patients hospitalized for acute myocardial infarction (Worcester Heart Attack Study).10
Characteristics of patients hospitalized with acute myocardial infarction (AMI) according to do-not-resuscitate (DNR) orders and timing (Worcester Heart Attack Study)10
| Characteristic | All DNR orders (n = 1051) | No DNR order written (n = 3131) | DNR order written prior to hospitalization (n = 364) | DNR order written during hospitalization (n = 678) | ||
|---|---|---|---|---|---|---|
| Age (years) | ||||||
| <65 | 5.7 | 40.4 | 2.8 | 7.3 | ||
| 65–74 | 11.6 | 23.2 | 8.0 | 13.0 | ||
| 75–84 | 37.7 | 27.0 | 41.9 | 35.5 | ||
| ≥85 | 45.0 | 9.3 | <0.001 | 47.4 | 44.3 | <0.001 |
| Female, % | 63.4 | 37.8 | <0.001 | 67.3 | 61.4 | <0.001 |
| Medical History, % | ||||||
| Angina pectoris | 17.5 | 18.2 | 0.61 | 14.8 | 19.3 | 0.21 |
| Diabetes mellitus | 36.6 | 33.0 | 0.03 | 36.0 | 37.0 | 0.18 |
| Hypertension | 78.3 | 71.3 | <0.001 | 75.8 | 79.7 | 0.09 |
| Heart failure | 43.2 | 18.5 | <0.001 | 48.9 | 40.4 | <0.001 |
| Stroke | 20.5 | 9.0 | <0.001 | 23.1 | 19.3 | <0.001 |
| Cancer | 19.9 | 14.0 | <0.001 | 21.4 | 19.0 | 0.33 |
| Liver disease | 0.9 | 1.21 | 0.49 | 0.82 | 1.03 | 0.76 |
| Renal disease | 28.4 | 15.5 | <0.001 | 32.7 | 26.4 | <0.001 |
| AMI characteristics | ||||||
| Initial | 54.5 | 68.3 | <0.001 | 55.0 | 54.1 | 0.88 |
| ST elevation | 24.1 | 35.8 | <0.001 | 21.2 | 25.4 | 0.02 |
| Clinical complications | ||||||
| Atrial fibrillation | 32.0 | 18.2 | <0.001 | 26.7 | 35.1 | <0.001 |
| Heart failure | 60.5 | 32.4 | <0.001 | 62.4 | 59.9 | 0.46 |
| Cardiogenic shock | 8.7 | 4.4 | <0.001 | 5.5 | 10.5 | <0.001 |
| Stroke | 3.6 | 0.9 | <0.001 | 1.4 | 4.7 | <0.001 |
| In-hospital medications | ||||||
| ACE inhibitors | 55.0 | 67.7 | <0.001 | 53.7 | 54.7 | 0.89 |
| Heparin/anticoagulants | 74.2 | 83.1 | <0.001 | 74.5 | 73.9 | 0.72 |
| Aspirin | 86.4 | 94.3 | <0.001 | 86.8 | 86.3 | 0.96 |
| Beta-blockers | 83.7 | 93.0 | <0.001 | 86.3 | 82.5 | 0.02 |
| Calcium antagonists | 26.7 | 23.2 | 0.02 | 26.1 | 27.4 | 0.39 |
| Thrombolytic therapy | 1.9 | 5.2 | <0.001 | 0.8 | 2.5 | <0.001 |
| Intervention procedures | ||||||
| Cardiac catheterization | 23.9 | 71.1 | <0.001 | 20.6 | 25.5 | <0.001 |
| Percutaneous coronary intervention | 14.9 | 50.4 | <0.001 | 12.4 | 16.4 | <0.001 |
| Coronary artery bypass surgery | 1.3 | 8.1 | <0.001 | 0.6 | 1.5 | <0.001 |
| Hospital case-fatality rate | 29.3 | 3.5 | <0.001 | 20.2 | 34.2 | <0.001 |
Notes:
P values compare patients with DNR orders written with those whose without DNR orders;
P values compare patients with DNR orders written prior to hospitalization with those whose DNR orders were written during hospitalization.
Abbreviation: ACE, angiotensin-converting enzyme.
Factors associated with having a do-not-resuscitate (DNR) order, and timing of the writing of the order, in patients hospitalized with acute myocardial infarction (AMI) (Worcester Heart Attack Study)10
| Characteristic | DNR order written | DNR order written after hospital admission | ||
|---|---|---|---|---|
|
|
| |||
| Model 1 | Model 2 | Model 1 | Model 2 | |
| Age, years | ||||
| <65 | 1.0 | 1.0 | 1.0 | 1.0 |
| 65–74 | 2.88 (2.04, 4.07) | 2.06 (1.41, 3.01) | 1.59 (0.68, 3.73) | 1.79 (0.74, 4.30) |
| 75–84 | 7.24 (5.32, 9.86) | 4.88 (3.48, 6.83) | 2.89 (1.35, 6.16) | 2.84 (1.30, 6.21) |
| ≥85 | 25.26 (18.27, 34.93) | 14.30 (10.00, 20.45) | 2.65 (1.24, 5.68) | 2.31 (1.05, 5.09) |
| Male | 0.51 (0.43, 0.61) | 0.52 (0.43, 0.63) | 0.76 (0.56, 1.01) | 0.76 (0.56, 1.04) |
| Medical history | ||||
| Angina pectoris | 0.70 (0.56, 0.87) | 0.81 (0.63, 1.03) | 0.71 (0.50, 1.04) | 0.67 (0.46, 0.99) |
| Diabetes mellitus | 1.11 (0.92, 1.33) | 1.09 (0.86, 1.34) | 1.01 (0.75, 1.37) | 1.04 (0.76, 1.41) |
| Hypertension | 0.78 (0.63, 0.96) | 0.86 (0.68, 1.09) | 0.74 (0.54, 1.04) | 0.75 (0.53, 1.06) |
| Heart failure | 2.22 (1.83, 2.69) | 1.67 (1.34, 2.08) | 1.59 (1.19, 2.13) | 1.58 (1.16, 2.15) |
| Stroke | 2.09 (1.66, 2.63) | 1.71 (1.33, 2.20) | 1.28 (0.91, 1.79) | 1.32 (0.93, 1.88) |
| AMI characteristics | ||||
| Initial | 0.74 (0.62, 0.89) | 0.74 (0.60, 0.90) | 1.12 (0.84, 1.50) | 1.18 (0.88, 1.58) |
| Anterior | 0.97 (0.74, 1.28) | 0.93 (0.68, 1.27) | 1.26 (0.80, 2.00) | 1.29 (0.81, 2.07) |
| ST segment elevation | 0.96 (0.76, 1.20) | 0.83 (0.64, 1.09) | 1.40 (0.96, 2.05) | 1.20 (0.80, 1.80) |
| Clinical complications | ||||
| Atrial fibrillation | 1.17 (0.95, 1.46) | 0.78 (0.57, 1.08) | ||
| Heart failure | 1.34 (1.09, 1.65) | 1.03 (0.76, 1.41) | ||
| Cardiogenic shock | 1.32 (0.86, 2.03) | 0.63 (0.34, 1.18) | ||
| Stroke | 2.20 (1.19, 4.07) | 0.29 (0.10, 0.86) | ||
| In-hospital medications | ||||
| ACE inhibitors | 0.91 (0.73, 1.11) | 0.74 (0.54, 1.01) | ||
| Heparin/anticoagulants | 0.99 (0.79, 1.25) | 1.05 (0.76, 1.48) | ||
| Aspirin | 1.34 (0.96, 1.87) | 0.98 (0.62, 1.55) | ||
| Beta-blockers | 1.03 (0.75, 1.41) | 1.34 (0.87, 2.09) | ||
| Calcium antagonists | 0.86 (0.71, 1.09) | 0.92 (0.66, 1.29) | ||
| Thrombolytic therapy | 0.56 (0.31, 1.04) | 0.44 (0.12, 1.61) | ||
| Diagnostic and interventional procedures | ||||
| Cardiac catheterization | 0.46 (0.34, 0.62) | 0.95 (0.55, 1.62) | ||
| Percutaneous coronary intervention | 0.66 (0.47, 0.92) | 1.06 (0.56, 1.98) | ||
| Coronary artery bypass surgery | 0.41 (0.22, 0.79) | 0.56 (0.11, 2.89) | ||
| Hospital death | 9.23 (6.74, 12.63) | 0.57 (0.39, 0.83) | ||
Notes: The respective referent categories are: age < 65 years, female sex, absence of selected medical history variables, previous AMI, non-Q wave AMI, inferior or posterior AMI, absence of selected clinical complications, absence of selected prescribed medications, absence of selected in-hospital procedures, and hospital survival status.
N = 4182;
analysis includes only patients with DNR orders, N = 1051.
Abbreviation: ACE, angiotensin-converting enzyme.